The global leader in healthcare naming!

Including nonproprietary (USAN/INN) names, drug brand names, medical device names, OTC product names, and COVID-19 vaccines, repurposed drugs, and diagnostics! We name over 75% of nonproprietary (USAN/INN) and drug brand name approvals worldwide!

1329
Healthcare Clients
4460
Total Healthcare Names
12
Tagline Names
Animal Health - 27
Antibiotic - 112
Antifungal - 28
Antiviral - 134
Antiviral/HIV - 52
Biologic Suffix - 62
Biosimilar Name - 29
Cardiovascular - 210
Class Name - 9
Clinical Trial Name - 120
Corporate Identity - 126
COVID-19 - 31
Covid-19 - 33
Dermatology - 149
Division Identity - 16
Endocrinology - 189
Gastrointestinal - 119
Hematology - 159
Identity Research - 15
Immunology - 261
Medical Device - 266
Men's Health - 11
Metabolic Disorders - 81
Musculoskeletal - 39
Nephrology - 34
Neurology - 389
Nutritional Agent - 53
Obesity - 16
Oncology - 818
Ophthalmology - 152
Oral Care - 8
OTC - 136
Pain & Inflammation - 171
Product Identity - 7
Program Name - 18
Respiratory - 221
Service Name - 17
Tagline - 12
Technology Name - 34
Urology - 26
USAN/INN - 1517
Vaccine - 107
Website - 24
Women's Health - 147

* Denotes a comprehensive report of the safety regulatory research prepared by B/DSI for submission of this name candidate to FDA, EMA, Health Canada, JMHLW, ANVISA, ROSZDRAVNADZOR, CDSCO, CFDA, KOREA MFDS, and/or other Regulatory Agencies.

CLIENTNAMECATEGORY
ASTELLAS ONCOLOGYCHANGING TOMORROW IN CANCER CARE Tagline
HCL AMERICAPRESCRIPTION EXCEPTION MANAGEMENT Tagline
HEALTH PLUSTHE RIGHT PLAN FOR A HEALTHIER YOU. Tagline
IMMATICS BIOTECHNOLOGIES GMBHDELIVERING THE POWER OF T CELLS TO CANCER PATIENTS Tagline
INNOVATIVE THERAPIESWOUND CARE. ANYWHERE. Tagline
MERCURY MEDICALSUPERIOR SOLUTIONS Tagline
NATIONAL FOUNDATION FOR CANCER RESEARCHWE MAKE CURES POSSIBLE Tagline
PHYSEONSIMPLE. SUPERIOR. SCIENCE Tagline
ST. JUDE MEDICALYOUR PARTNER IN VAD CARE Tagline
VERMILLIONTHE OVARIAN CANCER TEST Tagline
VERMILLIONTHE PAD TEST Tagline
VERMILLIONYOUR HEALTH. OUR PASSION Tagline